GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the USBusiness Wire • 06/16/25
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.Investors Business Daily • 06/09/25
FDA Accepts GSK's NDA for Linerixibat in Rare Disease-Related ItchZacks Investment Research • 06/03/25
Dow Jones Industrial Average (DIA) Live June 3: OECD Cuts US GDP Forecast, DIA Dives24/7 Wall Street • 06/03/25
Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 MillionPRNewsWire • 06/02/25
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 05/29/25
Buy 5 High Dividend-Paying Giants to Stay Safe Amid Volatile MarketsZacks Investment Research • 05/29/25
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring CommitteeGlobeNewsWire • 05/28/25
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)Business Wire • 05/22/25
Gilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now?Zacks Investment Research • 05/20/25
GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugZacks Investment Research • 05/15/25
GSK splashes out $1.2bn up-front for liver treatment still in clinical trialsProactive Investors • 05/14/25
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)Business Wire • 05/14/25